Lumbar spine bone mineral density predicts endothelial reactivity in patients with systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 29, Issue 2, 2011, Pages 261-268

  Mak, Anselm ^a,b   Ling, L H ^a,b   Ho, R C M ^b   Gong, L ^a,b   Cheak, A A C ^b   Yee, H ^a,b   Vasoo, S ^a   Koh, D R ^a,b   Robless, P A ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Atherosclerosis; Bone loss; Endothelial dysfunction; Inflammation; Osteoporosis; SLE

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTERIAL WALL THICKNESS; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; BONE DENSITY; BRACHIAL ARTERY; CONTROLLED STUDY; DISEASE ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOTHELIAL DYSFUNCTION; FEMALE; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; SEROLOGY; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRASOUND; ATHEROSCLEROSIS; LUMBAR VERTEBRA; METABOLIC BONE DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PREDICTIVE VALUE; RADIOGRAPHY; STATISTICAL MODEL; VASCULAR ENDOTHELIUM; VASODILATATION;

ABSORPTIOMETRY, PHOTON; ADULT; ATHEROSCLEROSIS; BONE DENSITY; BONE DISEASES, METABOLIC; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LOGISTIC MODELS; LUMBAR VERTEBRAE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; VASODILATION;

EID: 79959515273     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. HOFBAUER LC, BRUECK CC, SHANAHAN CM, SCHOPPET M, DOBNIG H: Vascular calcification and osteoporosis-from clinical observation towards molecular understanding. Osteoporos Int 2007; 18: 251-9.
2. DOHERTY TM, DETRANO RC: Coronary arterial calcification as an active process: a new perspective on an old problem. Calcif Tissue Int 1994; 54: 224-30.
3. VON MÜHLEN D, ALLISON M, JASSALSK, BARRETT-CONNOR E: Peripheral arterial disease and osteoporosis in older adults: the Rancho Bernardo Study. Osteoporos Int 2009; 20: 2071-8.
4. SZULC P, SAMELSON EJ, KIEL DP, DELMAS PD: Increased bone resorption is associated with increased risk of cardiovascular events in men: the MINOS study. J Bone Miner Res 2009; 24: 2023-31.
5. HMAMOUCHI I, ALLALI F, KHAZZANI H et al.: Low bone mineral density is related to atherosclerosis in postmenopausal Moroccan women. BMC public health 2009; 9: 388.
6. FERNANDES G, BHATTACHARYA A, RAHMAN M, ZAMAN M, ZAMAN K, BANU J: Effects of n-3 fatty acids on autoimmunity and osteoporosis. Front Biosci 2008; 13: 4015-20.
7. DAVÌ G, FALCO A: Oxidant stress, inflammation and atherogenesis. Lupus 2005; 14: 760-4.
8. RAMSEY-GOLDMAN R, MANZI S: Association of osteoporosis and cardiovascular disease in women with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2338-41.
9. RIBEIRO GG, BONFA E, NETO S et al.: Premature coronary artery calcification is associated with disease duration and bone mineral density in young female systemic lupus erythematosus patients. Lupus 2010; 19: 27-33.
10. INOUE T, MATSUOKA H, HIGASHI Y et al.: Flow-mediated vasodilation as a diagnostic modality for vascular failure. Hypertens Res 2008; 31: 2105-13.
11. CELERMAJER DS, SORENSEN KE, GOOCH VM et al.: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.
12. GHIADONI L, MOSCA M, TANI C et al.: Clinical and methodological aspects of endothelial function in patients with systemic autoimmune diseases. Clin Exp Rheumatol 2008; 26: 680-7.
13. SOGA J, NAKAMURA S, NISHIOKA K et al.: Relationship between augmentation index and flow-mediated vasodilation in the brachial artery. Hypertens Res 2008; 31: 1293-8.
14. GOKCE N, HOLBROOK M, HUNTER LM et al.: Acute effects of vasoactive drug treatment on brachial artery reactivity. Am Coll Cardiol 2002; 40: 761-5.
15. STEIN JH, KORCARZ CE, HURST RT et al.: American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008; 21: 93-111.
16. DELMAS PD: Do we need to change the WHO definition of osteoporosis? Osteoporos Int 2000; 11: 189-91.
17. L-MAGADMI M, BODILL H, AHMAD Y et al.: Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 2004; 110: 399-404.
18. PIPER MK, RAZA K, NUTTALL SL et al.: Impaired endothelial function in systemic lupus erythematosus. Lupus 2007; 16: 84-8.
19. CYPIENE A, KOVAITE M, VENALIS A et al.: Arterial wall dysfunction in systemic lupus erythematosus. Lupus 2009; 18: 522-9.
20. GHOSH P, KUMAR A, KUMAR S, AGGARWAL A, SINHA N, MISRA R: Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus. Clin Rheumatol 2009; 28: 1259-65.
21. JOHNSON SR, HARVEY PJ, FLORAS JS et al.: Impaired brachial artery endothelium dependent flow mediated dilation in systemic lupus erythematosus: preliminary observations. Lupus 2004; 13: 590-3.
22. TANI C, MOSCA M, D'ASCANIO A et al.: Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD. Reumatismo 2006; 58: 212-8.
23. VALDIVIELSO P, GOMEZ-DOBLAS JJ, MACIAS M et al.: Lupus-associated endothelial dysfunction, disease activity and arteriosclerosis. Clin Exp Rheumatol 2008; 26: 827-33.
24. WAJED J, AHMAD Y, DURRINGTON PN, BRUCE IN: Prevention of cardiovascular disease in systemic lupus erythematosus - proposed guidelines for risk factor management. Rheumatology (Oxford) 2004; 43: 7-12.
25. LIU SZ, YAN H, HOU WK et al.: Relationships between endothelial nitric oxide synthease gene polymorphisms and osteoporosis in postmenopausal women. Zhejiang Univ Sci B 2009; 10: 609-18.
26. VAN'T HOF RJ, RALSTON SH: Nitric oxide and bone. Immunology 2001; 103: 255-61.
27. ABRAMSON SB, AMIN AR, CLANCY RM, ATTUR M: The role of nitric oxide in tissue destruction. Best Pract Res Clin Rheumatol 2001; 15: 831-45.
28. FURUSU A, MIYAZAKI M, ABE K et al.: Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int 1998; 53: 1760-8.
29. VAZGIOURAKIS V, SIDIROPOULOS P, BERTSIAS G et al.: Association of the nitric oxide synthase (eNOS) gene polymorphism with increased risk for both lupus glomerulonephritis and rheumatoid arthritis in a single genetically homogeneous population. Lupus 2007; 16: 867-74.
30. HOFBAUER LC, BRUECK CC, SHANAHAN CM et al.: Vascular calcification and osteoporosis - from clinical observation towards molecular understanding. Osteoporos Int 2007; 18: 251-9.
31. GIACHELLI CM, BAE N, ALMEIDA M et al.: Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993; 92: 1686-96.
32. JONO S, IKARI Y, SHIOI A et al.: Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 2002; 106: 1192-4.
33. WITZTUM JL, STEINBERG D: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-92.
34. PARHAMI F, MORROW AD, BALUCAN J et al.: Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 1997; 17: 680-7.
35. KALLA AA, FATAAR AB, JESSOP SJ, BEWETUNGE L: Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993; 36: 1726-34.
36. HOUSSIAU FA, LEFEBVRE C, DEPRESSEUX G et al.: Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 1996; 35: 244-7.
37. BATUCA J, DELGADO ALVES J: C-reactive protein in systemic lupus erythematosus. Autoimmunity 2009; 42: 282-5.